Matrix

The innovation themes

Following the call to ideas of July 2009, the BioWin matrix has been reviewed and improved.  The axis of therapeutic fields has been abandoned. From now on, the R&D, supported by the  cluster, covers all fields related to health.

8 technological themes

8 technological themes have been defined :

• Biomarkers + in vitro & in vivo diagnostic (including biomedical imaging)

• Innovative tools and instrumentation (for hospitals, labs or industry, e.g. nano-surfaces for cell culture, disposable cell incubators, ...)

• Drug delivery systems (e.g. innovative formulations, drug targeting, ...)

• Novel therapies (e.g. regenerative medecine, cell therapy, siRNA therapies, …)

• Information technologies applied to human health (e.g. integration/analysis/  dissemination of diagnostic and radiological images , PK/PD and drug disease modelling, e-prescribing, electronic patient records, …)

• Innovative processes and organisational innovations (e.g. green chemistry synthesis, continuous production processes, new market access strategies)

• Medical devices (sub-cutaneaous implants, microneedles, minimal invasive surgery equipment, ...)

• Drug discovery (including antibody drug discovery, therapeutic vaccines discovery, …)
  

The « time to market » dimension

In addition to the technological dimension, the new BioWin matrix includes a “time to market” dimension.

• human health (including hospital related services)
• animal health.